• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Bullous Pemphigoid Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: The NetherlandsChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Current and Emerging Therapeutic Options for Children With Atopic Dermatitis
Dermatology
16 min
expert video

Current and Emerging Therapeutic Options for Children With Atopic Dermatitis

Emerging Real-World Data on Advanced Systemic Therapies in AD
Dermatology
5 min
expert video

Emerging Real-World Data on Advanced Systemic Therapies in AD

Early Intervention and the Potential For Disease Modification in AD
Dermatology
5 min
expert video

Early Intervention and the Potential For Disease Modification in AD

The Role of Type 2 Inflammation in Moderate-to-Severe AD
Dermatology
4 min
expert video

The Role of Type 2 Inflammation in Moderate-to-Severe AD

ADVENT On Air - Dermatology
Dermatology
45 min
Podcast

ADVENT On Air | Expert Discussions in Dermatology

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management
Gastroenterology
35 min
expert video

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

UEGW 2024 | Latest Clinical Evidence for Biologics in EoE
Gastroenterology
11 min
expert video

UEGW 2024 | Latest Clinical Evidence for Biologics in EoE

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?
Gastroenterology
11 min
expert video

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?

UEGW 2024 | WHY Is Long-Term Management of EoE Important?
Gastroenterology
10 min
expert video

UEGW 2024 | WHY Is Long-Term Management of EoE Important?

Real-World Effectiveness of Advanced Systemic Treatments in AD
Dermatology
6 min
expert video

Real-World Effectiveness of Advanced Systemic Treatments in AD

Pathophysiology of Blister Formation in Bullous Pemphigoid
Dermatology
2 min
expert video

Pathophysiology of Blister Formation in Bullous Pemphigoid

Factors Contributing to Diagnostic Delays in Bullous Pemphigoid
Dermatology
2 min
expert video

Factors Contributing to Diagnostic Delays in Bullous Pemphigoid

    1
    ...
    131415
    ...
    29